Research > Neurosciences

Neuroimmunology

Number of publications
89
Publications search
  • Munoz-Lopetegi, A; Pujol, M; Gimenez, M; Gaig, C; Brieva, L; Santamaria, J

    Abnormal sleep behavior caused by hypoglycemia

    SLEEP MEDICINE 85 268-270. .

    [doi:10.1016/j.sleep.2021.07.029]

  • Jorge C; Cetó M; Arias A; Blasco E; Gil MP; López R; Dakterzada F; Purroy F; Piñol-Ripoll G

    Level of understanding of Alzheimer disease among caregivers and the general population.

    Neurologia (barcelona, Spain) 36 426-432. .

    [doi:10.1016/j.nrleng.2018.03.004]

  • Meca-Lallana J; García-Merino JA; Martínez-Yélamos S; Vidal-Jordana A; Costa L; Eichau S; Rovira À; Brieva L; Agüera E; Zarranz AR

    Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.

    Neurodegenerative Disease Management 11 251-261. .

    [doi:10.2217/nmt-2020-0049]

  • Sánchez-Cazalilla M; González-Mingot C; Torterolo G; Torrent A; Batalla I

    Episodic Ataxia Misdiagnosed as Anxiety Disorder.

    The Primary Care Companion For Cns Disorders 23 -. .

    [doi:10.4088/PCC.20l02730]

  • Maurino J; Sotoca J; Sempere ÁP; Brieva L; López de Silanes C; Caminero AB; Terzaghi M; Gracia-Gil J; Saposnik G

    High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.

    Patient-Patient Centered Outcomes Research 14 241-248. .

    [doi:10.1007/s40271-020-00454-3]

  • Fernandez-Velasco, JI; Kuhle, J; Monreal, E; Meca-Lallana, V; Meca-Lallana, J; Izquierdo, G; Gascon-Gimenez, F; de la Maza, SS; Walo-Delgado, PE; Maceski, A; Rodriguez-Martin, E; Roldan, E; Villarrubia, N; Saiz, A; Blanco, Y; Sanchez, P; Carreon-Guarnizo, E; Aladro, Y; Brieva, L; Iniguez, C; Gonzalez-Suarez, I; de Antonio, LAR; Masjuan, J; Costa-Frossard, L; Villar, LM

    Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS

    Neurology-Neuroimmunology & Neuroinflammation 8 e940-. .

    [doi:10.1212/NXI.0000000000000940]

  • Otero-Romero S; Rodríguez-García J; Vilella A; Ara JR; Brieva L; Calles C; Carmona O; Casanova V; Costa-Frossard L; Eichau S; García-Merino JA; Garcia-Vidal C; González-Platas M; Llaneza M; Martínez-Ginés M; Meca-Lallana JE; Prieto JM; Rodríguez-Antigüedad A; Tintoré M; Blanco Y; Moral E; en nombre del Grupo de enfermedades desmielizantes de la SEN

    Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.

    Neurologia (barcelona, Spain) 36 50-60. .

    [doi:10.1016/j.nrl.2020.02.006]

  • Purroy F; Vicente-Pascual M; Arque G; Baraldes-Rovira M; Begue R; Gallego Y; Gil MI; Gil-Villar MP; Mauri G; Quilez A; Sanahuja J; Vazquez-Justes D

    Sex-Related Differences in Clinical Features, Neuroimaging, and Long-Term Prognosis After Transient Ischemic Attack.

    STROKE 52 424-433. .

    [doi:10.1161/STROKEAHA.120.032814]

  • Avila, A; Pastor, P; Planellas, L; Gil-Villar, MP; Hernandez-Vara, J; Fernandez-Dorado, A

    DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia

    REVISTA DE NEUROLOGIA 72 1-8. .

    [doi:10.33588/rn.7201.2020181]

  • Vázquez-Justes D; Peñalva-García J; López R; Mitjana R; Begue R; González-Mingot C

    Parkinsonism phenotype in a family with adult onset Alexander disease and a novel mutation of GFAP.

    CLIN NEUROL NEUROSUR 195 105893-105893. .

    [doi:10.1016/j.clineuro.2020.105893]

  • Meca-Lallana JE; Fernández-Prada M; García Vázquez E; Moreno Guillén S; Otero Romero S; Rus Hidalgo M; Villar Guimerans LM; Eichau Madueño S; Fernández Fernández Ó; Izquierdo Ayuso G; Álvarez Cermeño JC; Arnal García C; Arroyo González R; Brieva Ruiz L; Calles Hernández C; García Merino A; González Platas M; Hernández Pérez MÁ; Moral Torres E; Olascoaga Urtaza J; Oliva-Nacarino P; Oreja-Guevara C; Ortiz Castillo R; Oterino A; Prieto González JM; Ramió-Torrentá L; Rodríguez-Antigüedad A; Saiz A; Tintoré M; Montalbán Gairin X

    Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    NEUROLOGIA -. .

    [doi:10.1016/j.nrl.2019.11.003]

  • Meca-Lallana, J; Maurino, J; Hernández-Pérez MÁ; Sempere, AP; Brieva, L; García-Arcelay E; Terzaghi, M; Saposnik, G; Ballesteros, J

    Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective.

    Neurology and Therapy 9 173-179. .

    [doi:10.1007/s40120-020-00176-6]